Doctor of Philosophy, Case Western Reserve University, 2021, Molecular Virology
Extracellular vesicles (EVs) are lipid-bilayer enclosed, cell-derived nanoparticles released constitutively by most cells. EVs carry proteins and nucleic acids from their cells of origin, facilitating intercellular communication through a variety of different pathways. These include signaling through cellular receptors, triggering immune responses, and delivering bioactive cargos after EV internalization. Viruses share many characteristics with EVs, including size, structure, and biogenesis pathways. Virally infected cells continue to release EVs, resulting in the production of virus-induced EVs that carry viral elements like proteins or RNAs. Viral fusion proteins – viral envelope glycoproteins that mediate virus/cell membrane fusion – are often incorporated by virus-induced EVs. In this work, we investigated the effect that viral fusion protein incorporation has on EV communication and functionality. First, we investigated the spike protein of the current pandemic virus SARS-CoV-2. Interestingly, we found that EVs released from spike expressing cells did incorporate this type I viral fusion protein. These spike(+) EVs displayed the spike protein in a conformation available for antibody binding, allowing the EVs to serve as decoy targets for neutralizing antibodies. This held true with both convalescent patient serum and a commercial neutralizing antibody, with the effect of reducing virus neutralization and increasing infection.
The second component of this work concerned the development of EV/cell membrane fusion assays to monitor EV cargo delivery. This EV communication pathway is particularly important in disease, where EVs are thought to be capable of influencing cells through membrane fusion and delivery of bioactive cargos to cell cytosol. We successfully developed two EV fusion assays, based on delivery of the proteins beta-lactamase and Cre-recombinase. In the third and final component of this work, we utilized these fusion assays to investigate the in (open full item for complete abstract)
Committee: John Tilton M.D. (Advisor); Alan Levine Ph.D. (Committee Chair); Alex Huang M.D./Ph.D. (Committee Member); Scott Sieg Ph.D. (Committee Member)
Subjects: Biomedical Research; Molecular Biology; Virology